New app aims to ease tough choices for brain injury families
NCT ID NCT05671874
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested a web-based tool designed to improve communication and decision-making between doctors and families of patients with severe acute brain injuries, such as stroke or traumatic brain injury. The tool helps prepare families for their role as decision-makers and gives doctors tailored patient information. The study enrolled 50 surrogate decision-makers to see if the tool is feasible and easy to use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- web/mobile/tablet-based digital decision aid and communication tool
- What this could lead to
- If successful, this tool could improve how families and doctors make difficult decisions together for patients with severe brain injuries.
- What could go wrong
- This is a small pilot study with only 50 participants, so results may not apply to all hospitals or families. The tool is meant to support decisions, not change medical outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria for surrogates and patients: * surrogate is age 18 years or older, no upper age limit; * documented surrogate decision-maker (official health care proxy, or legal next of kin) of a critically ill severe acute brain injury (SABI) patient ≥ 3 days after admission; * patient is age 18 years or older, no upper age limit; * patient has SABI; defined as either traumatic brain injury, spontaneous primary intracerebral hemorrhage (not due to tumor or vascular malformation), or hemispheric acute ischemic stroke; * patient is"critically ill" defined as either intubated on a mechanical ventilator, or unable to swallow without a feeding tube (even if not intubated/ventilated); * patient is judged by the attending physician to have ≥40% risk of death or long-term functional impairment, elicited by asking the attending physician, "does this patient have at least a 40% chance of in-hospital mortality or long-term functional impairment?", defined as needing assistance with at least 1 activity of daily living (ADL). * patient has undergone initial stabilization but remains critically ill; * surrogate will participate in clinician-family goals of care meeting, either in person or via video- or telephone-conference. * surrogate must be English speaking and literate Exclusion Criteria for surrogates and patients: * devastating patients with severe SABI who die early (within the first 3 days after admission); * surrogate decision-maker is non-English speaking; * surrogate decision-maker is illiterate. Inclusion criteria for clinicians: * clinical treating attending, or physician trainee (fellow, resident), or licensed affiliated practitioner who will lead the clinician-family meeting when goals-of-care are discussed; * clinician may decline participation in the outcome measures but cannot restrict the surrogate decision-maker in study participation. Exclusion criteria for clinicians: \- unwillingness to comply with study protocol.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute ischemic stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
UMass Memorial Hospital
Worcester, Massachusetts, 01655, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can group wellness classes improve life after brain injury or dementia?
- Can a kidney protein drug boost stroke recovery after clot removal?
- Can a web program rebuild memory after brain injury?
- Can PET scans reveal hidden heart inflammation after a stroke?
- Can an implanted heart monitor catch hidden irregular heartbeats after stroke?
- China builds national watchdog for brain blood vessel devices